HOME › DRUGS › OCRELIZUMAB
ACTIVE SUBSTANCE / INN

OCRELIZUMAB

Brand name(s): Ocrevus, OCREVUS
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761053
Multiple Sclerosis
ACTIVE SUBSTANCE
Ocrelizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration GmbH, GENENTECH INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OCREVUSBLA761053GENENTECH INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OcrevusRoche Registration GmbHAuthorised08/01/2018Multiple Sclerosis

FULL INTELLIGENCE ON OCRELIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →